Aptevo Therapeutics Inc. (APVO)

NASDAQ: APVO · Real-Time Price · USD

0.50

-0.03 (-5.66%)

At close: May 01, 2025, 3:57 PM

0.50

0.97%

After-hours: May 01, 2025, 07:39 PM EDT

Aptevo Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	3.11M	12.29M	4.31M	32.42M	23.07M	14.66M	36.43M
Cost of Revenue	n/a	567K	901K	18.99M	17.85M	19.93M	11.21M	5.01M	24.18M
Gross Profit	n/a	-567K	2.21M	-6.7M	-13.54M	12.5M	11.85M	9.65M	12.25M
Operating Income	-24.6M	-28.88M	-28.64M	-21.4M	-27.49M	-40.96M	-51.66M	-53.95M	-126.94M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-24.13M	-18.65M	7.01M	-29.41M	-30.92M	-43.06M	-53.69M	-55.89M	-127.75M
Net Income	-24.13M	-17.41M	42.67M	-27.31M	-18.45M	-40.45M	-53.69M	6.97M	-112.42M
Selling & General & Admin	10.22M	11.77M	13.87M	14.7M	13.95M	16.2M	28.13M	34.58M	38.67M
Research & Development	14.38M	17.11M	17.88M	18.99M	17.85M	24.76M	35.38M	29.02M	29.52M
Other Expenses	n/a	n/a	-1.53M	-8.01M	-1.32M	-2.1M	-2.02M	34.58M	38.67M
Operating Expenses	24.6M	28.88M	31.75M	33.69M	31.8M	40.96M	63.52M	63.6M	68.18M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	28.88M	31.75M	33.69M	31.8M	40.96M	74.73M	68.61M	92.37M
Income Tax Expense	n/a	n/a	-35.66M	-2.1M	-12.47M	-2.62M	-2.02M	-23.3M	-15.34M
Shares Outstanding (Basic)	285K	278.06K	115.92K	106.54K	77.07K	4.74K	36.53K	34.63K	32.85K
Shares Outstanding (Diluted)	285K	278.06K	115.97K	106.54K	77.07K	4.74K	36.53K	34.63K	32.85K
EPS (Basic)	-84.67	-62.62	69.25	-267.09	-416.37	-9.44K	-1.47K	-1.32K	-3.42K
EPS (Diluted)	-84.67	-62.62	69.21	-267.09	-416.37	-9.44K	-1.47K	-1.32K	-3.42K
EBITDA	-24.6M	-28.31M	-27.74M	-20.26M	-26.09M	-39.53M	-49.27M	-50.82M	-64.4M
EBIT	n/a	-28.88M	-28.64M	-21.4M	-27.49M	-43.06M	-51.66M	-53.95M	-67.76M
Depreciation & Amortization	n/a	567K	901K	1.14M	1.41M	2.23M	2.39M	2.3M	1.9M